Clinical Study
Dexmedetomidine versus Remifentanil for Sedation during Awake Fiberoptic Intubation
Table 2
Patient demographics between the two groups.
| | Remifentanil (REM) | Dexmedetomidine (DEX) | value |
| Number of patients | 17 | 13 | | Age (yrs) | | | 0.89 | Mallampati (I, II, III, IV) (%) | 1/5/9/2 (8%, 31%, 54%, 15%) | 4/5/1/3 (30%, 40%, 10%, 20%) | 0.15 | ASA (1, 2, 3) (%) | 1/14/2 (5%, 83%,12%) | 0/4/9 (0%, 31%, 69%) | 0.96 | Height (cm) | | | 0.43 | Weight (kg) | | | 0.04 | BMI (kg/m2) | | | 0.13 | Thyromental (cm) | 7.2 | 6.1 | 0.08 |
|
|